Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| JPMorgan Chase & Co. | Institution | 21 028 373 | 10,12% | US$ 88,95M | 2026-05-18 |
| Sofinnova Partners SAS | Institution | 19 086 050 | 9,19% | US$ 80,73M | 2025-12-31 |
| Invus Public Equities, L.P. | Institution | 15 945 067 | 7,68% | US$ 67,45M | 2025-11-13 |
| Artal Group S.A. | Institution | 15 945 067 | 7,68% | US$ 67,45M | 2025-11-13 |
| Biodiscovery 6 FPCI | Institution | 14 114 476 | 6,80% | US$ 59,70M | 2025-12-31 |
| Andera Partners | Institution | 14 114 476 | 6,80% | US$ 59,70M | 2026-03-31 |
| Samsara BioCapital LLC | Institution | 13 540 194 | 6,52% | US$ 57,28M | 2026-03-31 |
| Sofinnova Crossover I | Institution | 12 332 804 | 5,94% | US$ 52,17M | 2025-12-31 |
| Eventide Healthcare Innovation Fund I LP | Institution | 9 368 517 | 4,51% | US$ 39,63M | 2025-12-31 |
| Eventide Asset Management, LLC | Institution | 9 368 517 | 4,51% | US$ 39,63M | 2026-03-31 |
| BVF Partners L.P. | Institution | 8 545 499 | 4,11% | US$ 36,15M | 2026-03-31 |
| New Enterprise Associates, Inc. | Institution | 8 350 730 | 4,02% | US$ 35,32M | 2026-03-31 |
| Samsara Biocapital, L.P. | Institution | 8 345 389 | 4,02% | US$ 35,30M | 2025-11-17 |
| Deep Track Capital, LP | Institution | 7 800 465 | 3,76% | US$ 33,00M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 7 800 465 | 3,76% | US$ 33,00M | 2026-03-31 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 6 945 995 | 3,34% | US$ 29,38M | 2025-09-30 |
| Perceptive Advisors LLC | Institution | 6 945 995 | 3,34% | US$ 29,38M | 2025-09-30 |
| Sofinnova Crossover Ii S.L.P. | Institution | 6 753 246 | 3,25% | US$ 28,57M | 2025-12-31 |
| New Enterprise Associates 17, L.P. | Institution | 6 684 064 | 3,22% | US$ 28,27M | 2026-03-30 |
| Mr. Frederic Cren | Initiés | 5 878 991 | 2,83% | US$ 24,87M | 2026-03-04 |
| Samsara Opportunity Fund, L.P. | Institution | 5 194 805 | 2,50% | US$ 21,97M | 2025-11-17 |
| Qatar Holding LLC | Institution | 5 157 233 | 2,48% | US$ 21,82M | 2025-07-22 |
| Caligan Partners, LP | Institution | 4 974 906 | 2,40% | US$ 21,04M | 2026-03-31 |
| Polar Capital Holdings Plc | Institution | 4 632 138 | 2,23% | US$ 19,59M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 4 630 461 | 2,23% | US$ 19,59M | 2025-11-17 |
| Paradigm Biocapital Advisors LP | Institution | 4 000 000 | 1,93% | US$ 16,92M | 2026-03-31 |
| Biomedical Value Fund | Institution | 3 658 944 | 1,76% | US$ 15,48M | 2025-09-30 |
| Great Point Partners, LLC | Institution | 3 449 937 | 1,66% | US$ 14,59M | 2025-12-31 |
| Dr. Pierre Broqua | Initiés | 3 428 070 | 1,65% | US$ 14,50M | 2026-03-04 |
| Biotechnology Value Fund II, L.P. | Institution | 3 321 861 | 1,60% | US$ 14,05M | 2025-11-17 |
| Millennium Management LLC | Institution | 2 987 613 | 1,44% | US$ 12,64M | 2026-03-31 |
| Trails Edge Capital Partners, LP | Institution | 2 657 997 | 1,28% | US$ 11,24M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 2 461 565 | 1,19% | US$ 10,41M | 2026-03-31 |
| Symbiosis Capital Partners, LLC | Institution | 2 354 000 | 1,13% | US$ 9,96M | 2026-03-31 |
| UBS Asset Management AG | Institution | 2 318 693 | 1,12% | US$ 9,81M | 2026-03-31 |
| Ally Bridge Group | Institution | 2 245 300 | 1,08% | US$ 9,50M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 2 174 398 | 1,05% | US$ 9,20M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1 932 160 | 0,93% | US$ 8,17M | 2026-03-31 |
| NEA 18 Venture Growth Equity, L.P. | Institution | 1 666 666 | 0,80% | US$ 7,05M | 2026-03-30 |
| Biomedical Offshore Value Fund, LTD. | Institution | 1 643 874 | 0,79% | US$ 6,95M | 2025-09-30 |
| Boothbay Fund Management, LLC | Institution | 1 470 407 | 0,71% | US$ 6,22M | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 1 429 101 | 0,69% | US$ 6,05M | 2026-03-31 |
| Inventiva S.A. Esop | Institution | 1 338 127 | 0,64% | US$ 5,66M | 2024-10-15 |
| Nextbio Capital Management Lp | Institution | 1 333 484 | 0,64% | US$ 5,64M | 2026-03-31 |
| RTW Investments, LP | Institution | 1 298 702 | 0,63% | US$ 5,49M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 956 221 | 0,46% | US$ 4,04M | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 844 215 | 0,41% | US$ 3,57M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
